| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Eyegate Pharmaceuticals (EYEG) | Aegis Capital Corp | $28.75 | n.a. | |||
| Grupo Aval Acciones Y Valores S.A. (AVAL) | J.P. Morgan/ Goldman Sachs | $100.00 | n.a. | |||
| TransFirst (TBA) | BofA Merrill Lynch/ Goldman Sachs/ J.P. Morgan/ Deutsche Bank Securities | $100.00 | n.a. | |||
| Virgin America (TBA) | Barclays/ Deutsche Bank Securities | $115.00 | n.a. | |||
| n.a. (not available) | ||||||
| TBA (to be announced) | ||||||
| Postponed | ||||||
| Lantheus Holdings (LNTH) | Citigroup/ Jefferies | 9.26 | $12.00 | $15.00 | $125.00 | 1-Star |
| Mapi – Pharma Ltd. (MAPI) | Aegis Capital Corp. | 2.25 | $8.00 | $8.00 | $18.00 | 1-Star |
| SIRVA (SRVA) | Morgan Stanley/ Goldman Sachs/ J.P. Morgan | 11.56 | $15.00 | $17.00 | $184.99 | 1-Star |
| Withdrawn | ||||||
| ProteinSimple (PRTN) | J.P. Morgan/ BofA Merrill Lynch | $86.25 | n.a. | |||
| New Terms | ||||||
| Avalanche Biotechnologies (AAVL) | Jefferies/ Cowen and Company/ Piper Jaffray | 5.40 | $16.00 | $17.00 | $89.10 | 3-Stars |
| C1 Financial (BNK) | Keefe, Bruyette & Woods (A Stifel Company)/ Raymond James | 2.63 | $18.00 | $20.00 | $50.00 | n.a. |
| FCB Financial Holdings (FCB) | Deutsche Bank Securities/ J.P. Morgan/ BofA Merrill Lynch | 7.52 | $22.00 | $23.00 | $169.20 | 1-Star |
| Green Bancorp (GNBC) | SANDLER O’NEILL + PARTNERS/ Jefferies | 4.69 | $15.00 | $17.00 | $75.00 | 1-Star |
| Hoegh LNG Partners LP (HMLP) | Citigroup/ BofA Merrill Lynch/ Morgan Stanley | 9.60 | $19.00 | $21.00 | $192.00 | 2-Stars |
| Independence Contract Drilling (ICD) | Morgan Stanley/ Barclays/ Tudor Pickering Holt | 10.00 | $14.00 | $16.00 | $150.00 | 2-Stars |
| Mobileye N.V. (MBLY) | Goldman Sachs/ Morgan Stanley | 27.75 | $21.00 | $23.00 | $610.50 | 3-Stars |
| Otonomy (OTIC) | J.P. Morgan/ BofA Merrill Lynch | 5.33 | $14.00 | $16.00 | $80.00 | n.a. |
| T2 Biosystems (TTOO) | Goldman Sachs/ Morgan Stanley | 4.00 | $15.00 | $17.00 | $64.00 | 1-Star |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of July 28, 2014 | Manager(s) | Offered | Raised | Price | 8/1/14 | Change |
| Avalanche Biotechnologies (AAVL) | Jefferies/ Cowen and Company/ Piper Jaffray | 6.00 | $102.00 | $17.00 | $25.16 | 48.00% |
| Mobileye N.V. (MBLY) | Goldman Sachs/ Morgan Stanley | 35.59 | $889.73 | $25.00 | $37.00 | 48.00% |
| Westlake Chemical Partners (WLKP) | Barclays/ UBS Investment Bank/ BofA Merrill Lynch/ Deutsche Bank Securities/ Morgan Stanley | 11.25 | $270.00 | $24.00 | $29.25 | 21.88% |
| HealthEquity (HQY) | J.P. Morgan/ Wells Fargo Securities | 9.10 | $127.40 | $14.00 | $16.95 | 21.07% |
| Transocean Partners (RIGP) | Morgan Stanley/ Barclay/ Citigroup/ J.P. Morgan/ Wells Fargo Securities | 17.50 | $385.00 | $22.00 | $24.60 | 11.82% |
| VTTI Energy Partners LP (VTTI) | Citigroup/ J.P. Morgan | 17.50 | $367.50 | $21.00 | $22.10 | 5.24% |
| ContraFect (CFRXU) (u) | Maxim Group LLC | 7.15 | $42.90 | $6.00 | $6.13 | 2.17% |
| Tekla Healthcare Opportunities Fund (THQ) | Wells Fargo Securities/ Morgan Stanley/ UBS Investment Bank/ Raymond James/ Ameriprise Financial Services | 38.50 | $770.00 | $20.00 | $20.01 | 0.05% |
| Marinus Pharmaceuticals (MRNS) | Stifel/ JMP Securities | 5.63 | $45.00 | $8.00 | $8.00 | 0.00% |
| Synchrony Financial (SYF) | Goldman Sachs/ J.P. Morgan/ Citigroup/ Morgan Stanley/ Barclays/ BofA Merrill Lynch/ Credit Suisse/ Deutsche Bank Securities | 125.00 | $2,875.00 | $23.00 | $23.00 | 0.00% |
| Loxo Oncology (LOXO) | Cowen and Company/ Stifel | 5.26 | $68.40 | $13.00 | $13.00 | 0.00% |
| Catalent (CTLT) | Morgan Stanley/ J.P. Morgan | 42.50 | $871.25 | $20.50 | $19.85 | -3.17% |
| Spark Energy (SPKE) | Baird/ Stifel | 3.00 | $54.00 | $18.00 | $17.19 | -4.50% |
| FCB Financial Holdings (FCB) | Deutsche Bank Securities/ J.P. Morgan/ BofA Merrill Lynch | 7.52 | $165.44 | $22.00 | $20.94 | -4.82% |
| Vascular Biogenics (VBLX) | Deutsche Bank Securities/ Wells Fargo Securities | 5.40 | $59.40 | $11.00 | $9.88 | -10.18% |
| Macrocure (MCUR) | Credit Suisse/ Jefferies | 5.35 | $53.50 | $10.00 | $7.49 | -25.10% |
| Bio Blast Pharma Ltd. (ORPN) | Oppenheimer/ Roth Capital Partners | 3.20 | $35.20 | $11.00 | $6.90 | -37.27% |
